CIK 0001125345
- Non-accelerated filer
- Smaller reporting company
MACROGENICS INC
Sign in to watch- Ticker
- MGNX
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Incorporated
- DE
- Entity type
- Operating
- Phone
- +1 301-251-5172
- Business address
- 9704 MEDICAL CENTER DRIVE, Rockville, MD, 20850
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $0
- in 0 filings
Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Reading 100 more Form 4s from the SEC; this list fills in as they're read.
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2021-04-15 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Sale | −5,000 | $30.91 | $155K | 0 |
| 2021-04-15 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Exercise or conversion · Employee stock option (right to buy) | −5,000 | $7.51 | $38K | 42,147 |
| 2021-03-22 | Karrels James SVP, CFO and Secretary | Sale | −15,000 | $33.00 | $495K | 143,460 |
| 2021-03-22 | Bonvini Ezio Sr VP, Research & CSO | Sale | −3,917 | $32.00 | $125K | 79,890 |
| 2021-03-08 | Peters Jeffrey Stuart General Counsel | Exercise or conversion | +21,749 | $11.50 | $250K | 21,749 |
| 2021-03-08 | Peters Jeffrey Stuart General Counsel | Sale | −21,749 | $26.50 | $576K | 0 |
| 2021-03-08 | Peters Jeffrey Stuart General Counsel | Exercise or conversion · Employee stock option (right to buy) | −21,749 | 65,251 | ||
| 2021-02-22 | Spitznagel Thomas Sr VP, BPD & Manufacturing | Grant or award · Employee stock option (right to buy) | +95,000 | 95,000 | ||
| 2021-02-22 | Risser Eric Blasius Sr VP & Chief Business Officer | Grant or award · Employee stock option (right to buy) | +95,000 | 95,000 | ||
| 2021-02-22 | Peters Jeffrey Stuart General Counsel | Grant or award · Employee stock option (right to buy) | +90,000 | 90,000 | ||
| 2021-02-22 | Koenig Scott President and CEO | Grant or award · Employee stock option (right to buy) | +280,000 | 280,000 | ||
| 2021-02-22 | Karrels James SVP, CFO and Secretary | Grant or award · Employee stock option (right to buy) | +95,000 | 95,000 | ||
| 2021-02-22 | Eck Stephen L. Chief Medical Officer | Grant or award · Employee stock option (right to buy) | +60,000 | 60,000 | ||
| 2021-02-22 | Cilinski Lynn VP, Controller and Treasurer | Grant or award · Employee stock option (right to buy) | +40,000 | 40,000 | ||
| 2021-02-22 | Bonvini Ezio Sr VP, Research & CSO | Grant or award · Employee stock option (right to buy) | +120,000 | 120,000 | ||
| 2021-02-10 | O'Brien Federica F. Director | Grant or award · Stock Option (right to buy) | +30,000 | 30,000 | ||
| 2021-01-28 | Karrels James SVP, CFO and Secretary | Exercise or conversion | +1,000 | $0.94 | $940 | 153,460 |
| 2021-01-28 | Karrels James SVP, CFO and Secretary | Exercise or conversion | +5,000 | $1.51 | $8K | 158,460 |
| 2021-01-28 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −1,000 | 0 | ||
| 2021-01-28 | Karrels James SVP, CFO and Secretary | Exercise or conversion · Employee stock option (right to buy) | −5,000 | 8,316 |
Page 24 of 26 · 503 trades